Home › Funds › Boxer Capital Management, LLC › AVTX

Boxer Capital Management, LLC position in AVTX

AVALO THERAPEUTICS INC · Health Care

Boxer Capital Management, LLC reported holding 375,000 shares of AVTX (AVALO THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$6.9M, representing 0.52% of its reported portfolio and ranking #35 among its reported holdings. Boxer Capital Management, LLC has disclosed AVTX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)375.00K sh
Reported value held$6.93M
Portfolio Weight0.52%
First reportedQ3 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Boxer Capital Management, LLC's AVTX position evolved

Boxer Capital Management, LLC first disclosed a stake in AVTX in Q3 2025 at 125,000 shares (US$1.6M). The position peaked in Q2 2026 at 375,000 shares, worth US$6.9M. Across 4 filings, Boxer Capital Management, LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 375,000 shares valued at US$6.9M — an increase of 75,000 shares quarter over quarter.. Notable position changes include a 120% increase in Q4 2025 (shares fell 18% over the following quarter), a 25% increase in Q2 2026 (shares fell 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 125.00K $1.59M New
Q4 2025 275.00K $4.99M Add
Q1 2026 300.00K $4.48M Add
Q2 2026 375.00K $6.93M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AVTX and 13F data

AVTX (AVALO THERAPEUTICS INC) is a Health Care company. 83 other funds we track also report a position in AVTX — the largest reported positions include Deep Track Capital, LP (US$66.7M), Caligan Partners LP (US$58.5M), TCG Crossover Management, LLC (US$55.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AVTX

All AVTX fund holders →

FAQ

How long has Boxer Capital Management, LLC held AVTX?

Boxer Capital Management, LLC has disclosed AVTX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Boxer Capital Management, LLC's current position in AVTX?

As of Q2 2026, Boxer Capital Management, LLC holds 375.00K shares of AVTX (AVALO THERAPEUTICS INC), valued at $6.93M, representing 0.52% of its reported portfolio and ranking #35.

Has Boxer Capital Management, LLC been buying or selling AVTX?

In the latest 13F filing (Q2 2026), Boxer Capital Management, LLC increased its position in AVTX. The position peaked in Q2 2026 at 375.00K shares.

Which other funds hold AVTX?

Other major institutional holders of AVTX include Deep Track Capital, LP, Caligan Partners LP, TCG Crossover Management, LLC, among 83 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.